비교리스트

 카트 문의
시장보고서
상품코드
1344377

대동맥류 수복 시장 : 제품 유형별, 시술 유형별 - 세계 기회 분석 및 산업 예측(2023-2032년)

Aortic Aneurysm Repair Market By Product Type (Aortic Stent-grafts, Hybrid stent-grafts), By Procedure Type (Open Surgery, Endovascular Aortic Aneurysm Repair, Frozen Elephant Trunk): Global Opportunity Analysis and Industry Forecast, 2023-2032
발행일: | 리서치사: Allied Market Research | 페이지 정보: 영문 226 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Allied Market Research가 발행한 최신 보고서 '대동맥류 수복 시장'에 따르면 대동맥류 수복 시장은 2022년 32억 달러로 평가되며 2023년부터 2032년까지 CAGR 6.1%로 성장해 2032년에는 58억 달러에 달할 것으로 추정됩니다.

Aortic Aneurysm Repair Market-IMG1

외과적 수복술은 일반적으로 개복 수술을 통해 확장된 대동맥의 일부를 합성 이식편으로 대체하는 방법입니다. 반면, 혈관내복원술은 작은 절개창을 통해 스텐트 이식편을 삽입하여 약해진 대동맥의 일부를 안쪽에서 보강하는 최소침습적 기술을 사용합니다. 치료 방법의 선택은 동맥류의 위치, 크기, 모양, 환자의 전신 상태 등의 요인에 따라 달라집니다. 대동맥류 수복는 대동맥의 정상적인 구조와 기능을 회복시켜 파열을 포함한 합병증의 위험을 줄이고 환자의 예후를 개선하는 것을 목표로 합니다.

대동맥류 수복 시장의 성장은 주로 대동맥류 및 관련 질환의 유병률 증가에 기인합니다. 대동맥류는 고령화 인구의 급격한 증가와 고혈압, 동맥경화, 흡연과 같은 위험 요소의 발생률 증가와 같은 요인으로 인해 더 흔하게 발생하고 있습니다. 또한 Medscape 저널에 발표된 논문에 따르면, 2022년 고혈압은 미국에서 가장 흔하게 진단되는 질환으로 약 8,600만 명의 성인(20세 이상)이 앓고 있으며, 뇌졸중, 심근경색, 혈관 질환의 주요 위험요인으로 작용할 것으로 예측했습니다. 따라서 전 세계적으로 고혈압 유병률이 계속 증가함에 따라 대동맥류 발병 위험에 처한 사람들의 수도 증가하여 시장 성장을 촉진할 것입니다.

그러나 대동맥류 수복 시장의 성장을 억제하는 요인은 여러 신흥국에서 특정 장비의 미비와 숙련된 의료진의 수가 제한적이라는 점입니다. 첨단 의료 장비와 기술에 대한 접근성이 부족하여 대동맥류에 대한 효과적인 치료를 방해하고 있습니다. 또한, 대동맥류 수복에 능숙한 숙련된 의료 전문가의 부족은 최적의 치료를 제공하는 능력을 제한하고 시장 성장을 더욱 저해합니다.

또한, 고급 의료 서비스에 대한 수요 증가와 대동맥류 수복에 대한 인식이 높아짐에 따라 예측 기간 동안 시장 확대에 유리한 기회를 제공할 것으로 예상됩니다. 또한, 정부의 유리한 상환 정책에 대한 이니셔티브의 급증은 고급 치료의 채택을 촉진하여 대동맥류 수리 시장의 성장을 눈에 띄게 촉진하고 있습니다.

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

  • 시장 정의와 범위
  • 주요 조사 결과
    • 영향요인
    • 주요 투자 기회
  • Porter's Five Forces 분석
  • 시장 역학
    • 성장 촉진요인
      • 대동맥류 유병률 상승
      • 최소침습 수술에 대한 수요 증가
      • 대동맥류 기기 제품 인가 증가
    • 성장 억제요인
      • 다양한 개발도상 지역의 특정 기기 부족
      • 숙련된 헬스케어 전문가 부족
    • 기회
      • 대동맥류 수복 기기의 기술적 진보
  • COVID-19에 의한 시장에 대한 영향 분석

제4장 대동맥류 수복 시장 : 제품 유형별

  • 대동맥 스텐트 그래프트
  • 하이브리드 스텐트 그래프트

제5장 대동맥류 수복 시장 : 시술 유형별

  • 개복 수술
    • 개복 수술에 의한 대동맥류 수복 시장 : 수복 유형별
  • 혈관내 대동맥류 재건술
    • 혈관내 대동맥류 재건술에 의한 대동맥류 재건술 시장 : 수복 유형별
  • FET(Frozen Elephant Trunk)

제6장 대동맥류 수복 시장 : 지역별

  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 기타 유럽
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 호주
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 라틴아메리카
    • 중동 및 아프리카

제7장 경쟁 상황

  • 서론
  • 주요 성공 전략
  • 주요 10개사 제품 매핑
  • 경쟁 대시보드
  • 경쟁 히트맵
  • 주요 기업의 포지셔닝, 2022년

제8장 기업 개요

  • Medtronic plc
  • Artivion, Inc.
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.
  • MicroPort Scientific Corporation
  • Cook Group Inc
  • Endologix Inc.
  • Cordis Corporation
  • Braile Biomedica S.A.
  • Bentley InnoMed GmbH
KSM 23.09.27

According to a new report published by Allied Market Research, titled, "Aortic Aneurysm Repair Market," The aortic aneurysm repair market was valued at $3.2 billion in 2022, and is estimated to reach $5.8 billion by 2032, growing at a CAGR of 6.1% from 2023 to 2032.

Aortic Aneurysm Repair Market - IMG1

Surgical repair typically involves open surgery, where a portion of the dilated aorta is replaced with a synthetic graft. On the other hand, endovascular repair involves minimally invasive techniques, such as the insertion of a stent graft through small incisions, to reinforce the weakened segment of the aorta from within. The choice of repair method depends on factors such as the location, size, and shape of the aneurysm, as well as the patient's overall health. Aortic aneurysm repair aims to reduce the risk of complications, including rupture, and improve patient outcomes by restoring the normal structure and function of the aorta.

The market growth for aortic aneurysm repair is primarily driven by the increase in the prevalence of aortic aneurysms and related diseases. Aortic aneurysms have become more common due to factors such as the surge in aging population and the rise in incidence of risk factors such as hypertension, atherosclerosis, and smoking. In addition, according to the article published by Medscape, in 2022, hypertension is the most common disease primarily diagnosed in the U.S., affecting approximately 86 million adults (≥20 years) and is a major risk factor for stroke, myocardial infarction, and vascular disease. Thus, as the prevalence of hypertension continues to rise globally, the number of individuals at risk of developing aortic aneurysms also increases, thereby driving the market growth.

However, the market growth for aortic aneurysm repair is restrained by the lack of availability of certain devices in various developing regions and limited availability of skilled healthcare professionals. Inadequate access to advanced medical devices and technologies hampers the effective treatment of aortic aneurysms. In addition, the scarcity of skilled healthcare professionals with expertise in aortic aneurysm repair limits the capacity to deliver optimal care, further impeding market growth.

Moreover, the increase in demand for advanced healthcare services and rise in awareness of aortic aneurysm treatments are expected to provide remunerative opportunities for the expansion of the market during the forecast period. Furthermore, the upsurge in initiatives by the government for favorable reimbursement policies fuel the adoption of advanced treatments and thereby notably driving the growth of the aortic aneurysm repair market.

The aortic aneurysm repair market is segmented into product type, procedure type, and region. By product type, the market is categorized into aortic stent-grafts and hybrid stent-grafts. On the basis of procedure type, it is segregated into open surgery, endovascular aortic aneurysm repair, and frozen elephant trunk (FET). The open surgery is further categorized into abdominal open repair and thoracic open repair. The endovascular aortic aneurysm repair is further categorized into abdominal endovascular aortic aneurysm repair , thoracic endovascular aortic aneurysm repair, and others (branched endovascular aortic repair, fenestrated endovascular aortic repair, branched thoracic endovascular aortic repair (B-TEVAR)).

Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America and Middle East and Africa).The key players operating in the aortic aneurysm repair market are Medtronic plc , Artivion, Inc, Terumo Corporation, W. L. Gore and Associates, Inc., MicroPort Scientific Corporation, Cook Group Inc, ENDOLOGIX LLC , Cordis Corporation., Bentley InnoMed GmbH and Braile Biomedica S.A. The key players have adopted strategies such as product launch, product approval and innovation to enhance their product portfolio.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the aortic aneurysm repair market analysis from 2022 to 2032 to identify the prevailing aortic aneurysm repair market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the aortic aneurysm repair market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global aortic aneurysm repair market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product Type

  • Aortic Stent-grafts
  • Hybrid stent-grafts

By Procedure Type

  • Open Surgery
    • Repair type
    • Abdominal Open Repair
    • Thoracic Open Repair
  • Endovascular Aortic Aneurysm Repair
    • Repair Type
    • Abdominal Endovascular Aortic Repair
    • Thoracic Endovascular Aortic Aneurysm Repair
    • Others
  • Frozen Elephant Trunk

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East And Africa

Key Market Players:

    • Artivion, Inc.
    • Bentley InnoMed GmbH
    • Braile Biomedica S.A.
    • Cook Group Inc
    • Cordis Corporation
    • Endologix Inc.
    • Medtronic plc
    • MicroPort Scientific Corporation
    • Terumo Corporation
    • W. L. Gore & Associates, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. High bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. High bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence of Aortic Aneurysms.
      • 3.4.1.2. Increase in demand for minimally invasive procedures
      • 3.4.1.3. Increase in product approval for aortic aneurysm devices
    • 3.4.2. Restraints
      • 3.4.2.1. Lack in the Availability of Certain Devices in Various Developing Regions
      • 3.4.2.2. Limited Availability of Skilled Healthcare Professionals
    • 3.4.3. Opportunities
      • 3.4.3.1. Technological advancements in aortic aneurysm repair devices
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: AORTIC ANEURYSM REPAIR MARKET, BY PRODUCT TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Aortic Stent-grafts
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Hybrid stent-grafts
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: AORTIC ANEURYSM REPAIR MARKET, BY PROCEDURE TYPE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Open Surgery
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
    • 5.2.4. Open Surgery Aortic Aneurysm Repair Market by Repair type
  • 5.3. Endovascular Aortic Aneurysm Repair
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
    • 5.3.4. Endovascular Aortic Aneurysm Repair Aortic Aneurysm Repair Market by Repair Type
  • 5.4. Frozen Elephant Trunk
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: AORTIC ANEURYSM REPAIR MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key trends and opportunities
    • 6.2.2. Market size and forecast, by Product Type
    • 6.2.3. Market size and forecast, by Procedure Type
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Key market trends, growth factors and opportunities
      • 6.2.4.1.2. Market size and forecast, by Product Type
      • 6.2.4.1.3. Market size and forecast, by Procedure Type
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Key market trends, growth factors and opportunities
      • 6.2.4.2.2. Market size and forecast, by Product Type
      • 6.2.4.2.3. Market size and forecast, by Procedure Type
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Key market trends, growth factors and opportunities
      • 6.2.4.3.2. Market size and forecast, by Product Type
      • 6.2.4.3.3. Market size and forecast, by Procedure Type
  • 6.3. Europe
    • 6.3.1. Key trends and opportunities
    • 6.3.2. Market size and forecast, by Product Type
    • 6.3.3. Market size and forecast, by Procedure Type
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Key market trends, growth factors and opportunities
      • 6.3.4.1.2. Market size and forecast, by Product Type
      • 6.3.4.1.3. Market size and forecast, by Procedure Type
      • 6.3.4.2. France
      • 6.3.4.2.1. Key market trends, growth factors and opportunities
      • 6.3.4.2.2. Market size and forecast, by Product Type
      • 6.3.4.2.3. Market size and forecast, by Procedure Type
      • 6.3.4.3. UK
      • 6.3.4.3.1. Key market trends, growth factors and opportunities
      • 6.3.4.3.2. Market size and forecast, by Product Type
      • 6.3.4.3.3. Market size and forecast, by Procedure Type
      • 6.3.4.4. Italy
      • 6.3.4.4.1. Key market trends, growth factors and opportunities
      • 6.3.4.4.2. Market size and forecast, by Product Type
      • 6.3.4.4.3. Market size and forecast, by Procedure Type
      • 6.3.4.5. Spain
      • 6.3.4.5.1. Key market trends, growth factors and opportunities
      • 6.3.4.5.2. Market size and forecast, by Product Type
      • 6.3.4.5.3. Market size and forecast, by Procedure Type
      • 6.3.4.6. Rest Of Europe
      • 6.3.4.6.1. Key market trends, growth factors and opportunities
      • 6.3.4.6.2. Market size and forecast, by Product Type
      • 6.3.4.6.3. Market size and forecast, by Procedure Type
  • 6.4. Asia-Pacific
    • 6.4.1. Key trends and opportunities
    • 6.4.2. Market size and forecast, by Product Type
    • 6.4.3. Market size and forecast, by Procedure Type
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. Japan
      • 6.4.4.1.1. Key market trends, growth factors and opportunities
      • 6.4.4.1.2. Market size and forecast, by Product Type
      • 6.4.4.1.3. Market size and forecast, by Procedure Type
      • 6.4.4.2. China
      • 6.4.4.2.1. Key market trends, growth factors and opportunities
      • 6.4.4.2.2. Market size and forecast, by Product Type
      • 6.4.4.2.3. Market size and forecast, by Procedure Type
      • 6.4.4.3. India
      • 6.4.4.3.1. Key market trends, growth factors and opportunities
      • 6.4.4.3.2. Market size and forecast, by Product Type
      • 6.4.4.3.3. Market size and forecast, by Procedure Type
      • 6.4.4.4. Australia
      • 6.4.4.4.1. Key market trends, growth factors and opportunities
      • 6.4.4.4.2. Market size and forecast, by Product Type
      • 6.4.4.4.3. Market size and forecast, by Procedure Type
      • 6.4.4.5. South Korea
      • 6.4.4.5.1. Key market trends, growth factors and opportunities
      • 6.4.4.5.2. Market size and forecast, by Product Type
      • 6.4.4.5.3. Market size and forecast, by Procedure Type
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Key market trends, growth factors and opportunities
      • 6.4.4.6.2. Market size and forecast, by Product Type
      • 6.4.4.6.3. Market size and forecast, by Procedure Type
  • 6.5. LAMEA
    • 6.5.1. Key trends and opportunities
    • 6.5.2. Market size and forecast, by Product Type
    • 6.5.3. Market size and forecast, by Procedure Type
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Latin America
      • 6.5.4.1.1. Key market trends, growth factors and opportunities
      • 6.5.4.1.2. Market size and forecast, by Product Type
      • 6.5.4.1.3. Market size and forecast, by Procedure Type
      • 6.5.4.2. Middle East And Africa
      • 6.5.4.2.1. Key market trends, growth factors and opportunities
      • 6.5.4.2.2. Market size and forecast, by Product Type
      • 6.5.4.2.3. Market size and forecast, by Procedure Type

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

  • 8.1. Medtronic plc
    • 8.1.1. Company overview
    • 8.1.2. Key Executives
    • 8.1.3. Company snapshot
    • 8.1.4. Operating business segments
    • 8.1.5. Product portfolio
    • 8.1.6. Business performance
  • 8.2. Artivion, Inc.
    • 8.2.1. Company overview
    • 8.2.2. Key Executives
    • 8.2.3. Company snapshot
    • 8.2.4. Operating business segments
    • 8.2.5. Product portfolio
    • 8.2.6. Business performance
  • 8.3. Terumo Corporation
    • 8.3.1. Company overview
    • 8.3.2. Key Executives
    • 8.3.3. Company snapshot
    • 8.3.4. Operating business segments
    • 8.3.5. Product portfolio
    • 8.3.6. Business performance
    • 8.3.7. Key strategic moves and developments
  • 8.4. W. L. Gore & Associates, Inc.
    • 8.4.1. Company overview
    • 8.4.2. Key Executives
    • 8.4.3. Company snapshot
    • 8.4.4. Operating business segments
    • 8.4.5. Product portfolio
    • 8.4.6. Key strategic moves and developments
  • 8.5. MicroPort Scientific Corporation
    • 8.5.1. Company overview
    • 8.5.2. Key Executives
    • 8.5.3. Company snapshot
    • 8.5.4. Operating business segments
    • 8.5.5. Product portfolio
    • 8.5.6. Business performance
    • 8.5.7. Key strategic moves and developments
  • 8.6. Cook Group Inc
    • 8.6.1. Company overview
    • 8.6.2. Key Executives
    • 8.6.3. Company snapshot
    • 8.6.4. Operating business segments
    • 8.6.5. Product portfolio
  • 8.7. Endologix Inc.
    • 8.7.1. Company overview
    • 8.7.2. Key Executives
    • 8.7.3. Company snapshot
    • 8.7.4. Operating business segments
    • 8.7.5. Product portfolio
    • 8.7.6. Key strategic moves and developments
  • 8.8. Cordis Corporation
    • 8.8.1. Company overview
    • 8.8.2. Key Executives
    • 8.8.3. Company snapshot
    • 8.8.4. Operating business segments
    • 8.8.5. Product portfolio
  • 8.9. Braile Biomedica S.A.
    • 8.9.1. Company overview
    • 8.9.2. Key Executives
    • 8.9.3. Company snapshot
    • 8.9.4. Operating business segments
    • 8.9.5. Product portfolio
  • 8.10. Bentley InnoMed GmbH
    • 8.10.1. Company overview
    • 8.10.2. Key Executives
    • 8.10.3. Company snapshot
    • 8.10.4. Operating business segments
    • 8.10.5. Product portfolio
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제